Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Medivation
>
Amgen interested in buying Medivation
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5669139"]I have a feeling this is just a big hype. It is going to be vey hard for any company trying to deal with Astellas. Just imagine what we have been dealing with in past 4-5 years. Lazy, no good attitude that comes from Astellas sales and management teams will not be a positive signal for any company to take over MDVN, unless they can get rid of Astellas as well.</p><p>That being said, looking at Portfolios, as Astellas handles all Amgen Oncology products in Japan, will make them ideal but from the other hand, Amgen has not done well in Oncology and has nothing in Breast Cancer or GU Cancers, I would argue that Pfizer, followed by Sanofi would be the top candidates for MDVN. Both those companies will try to make a deal with both MDVN and Astellas to get the full control over Xtandi and they truly don't need any of us.</p><p>You have to go to SEC web site, find out when is the next opening, legal schedule sell fog shares for our executive team and board members, then take a look at the number of shares scheduled to be sold, any period, showing the most share scheduled to be sold, short time after that, will be the time that board will sign off the deal![/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5669139"]I have a feeling this is just a big hype. It is going to be vey hard for any company trying to deal with Astellas. Just imagine what we have been dealing with in past 4-5 years. Lazy, no good attitude that comes from Astellas sales and management teams will not be a positive signal for any company to take over MDVN, unless they can get rid of Astellas as well. That being said, looking at Portfolios, as Astellas handles all Amgen Oncology products in Japan, will make them ideal but from the other hand, Amgen has not done well in Oncology and has nothing in Breast Cancer or GU Cancers, I would argue that Pfizer, followed by Sanofi would be the top candidates for MDVN. Both those companies will try to make a deal with both MDVN and Astellas to get the full control over Xtandi and they truly don't need any of us. You have to go to SEC web site, find out when is the next opening, legal schedule sell fog shares for our executive team and board members, then take a look at the number of shares scheduled to be sold, any period, showing the most share scheduled to be sold, short time after that, will be the time that board will sign off the deal![/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Medivation
>
Amgen interested in buying Medivation
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Medivation
>
Amgen interested in buying Medivation
>